Quote | Sight Sciences Inc. (NASDAQ:SGHT)
Last: | $5.34 |
---|---|
Change Percent: | 1.2% |
Open: | $5.74 |
Close: | $5.34 |
High: | $5.74 |
Low: | $5.3 |
Volume: | 167,178 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | Sight Sciences Inc. (NASDAQ:SGHT)
2024-05-06 20:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-05 01:58:11 ET Sight Sciences, Inc. (SGHT) Q1 2024 Earnings Conference Call May 02, 2024 04:30 PM ET Company Participants Philip Trip Taylor - Investor Relations Paul Badawi - Co-Founder and Chief Executive Officer Alison Bauerlein - Chief Financial Offic...
Message Board Posts | Sight Sciences Inc. (NASDAQ:SGHT)
Subject | By | Source | When |
---|---|---|---|
Picked up some more @ 22 | Southern Gal | investorshub | 10/11/2021 2:38:19 PM |
MENLO PARK, Calif., July 14, 2021 (GLOBE NEWSWIRE) | Southern Gal | investorshub | 07/15/2021 2:31:45 PM |
SGHT GOING PUBLIC THIS MORNING @ $24 | Southern Gal | investorshub | 07/15/2021 2:31:11 PM |
hmm? | MrSparex | investorshub | 02/08/2007 3:54:16 AM |
...exciting board eh? | MrSparex | investorshub | 10/30/2006 3:24:15 AM |
News, Short Squeeze, Breakout and More Instantly...
Sight Sciences Inc. Company Name:
SGHT Stock Symbol:
NASDAQ Market:
MENLO PARK, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technolo...
2024-05-06 20:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MENLO PARK, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today reported financial...